ATE326453T1 - Antithrombotische amide - Google Patents
Antithrombotische amideInfo
- Publication number
- ATE326453T1 ATE326453T1 AT99964269T AT99964269T ATE326453T1 AT E326453 T1 ATE326453 T1 AT E326453T1 AT 99964269 T AT99964269 T AT 99964269T AT 99964269 T AT99964269 T AT 99964269T AT E326453 T1 ATE326453 T1 AT E326453T1
- Authority
- AT
- Austria
- Prior art keywords
- antithrbotic
- amides
- inhibitor
- factor
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11377898P | 1998-12-23 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE326453T1 true ATE326453T1 (de) | 2006-06-15 |
Family
ID=22351471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99964269T ATE326453T1 (de) | 1998-12-23 | 1999-12-15 | Antithrombotische amide |
Country Status (9)
Country | Link |
---|---|
US (5) | US6610704B1 (de) |
EP (1) | EP1140881B1 (de) |
JP (1) | JP2004522689A (de) |
AT (1) | ATE326453T1 (de) |
AU (1) | AU2054700A (de) |
CA (1) | CA2358091A1 (de) |
DE (1) | DE69931393T2 (de) |
ES (1) | ES2263294T3 (de) |
WO (1) | WO2000039111A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999000126A1 (en) | 1997-06-26 | 1999-01-07 | Eli Lilly And Company | Antithrombotic agents |
EP1007037A4 (de) | 1997-06-26 | 2004-10-06 | Lilly Co Eli | Antithrombose mittel |
CA2294042A1 (en) | 1997-06-26 | 1999-01-07 | David Kent Herron | Antithrombotic agents |
AU8270298A (en) | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
ES2226485T3 (es) | 1998-12-23 | 2005-03-16 | Eli Lilly And Company | Amidas aromaticas. |
US6689780B1 (en) | 1998-12-23 | 2004-02-10 | Eli Lilly And Company | Heteroroaromatic amides as inhibitor of factor Xa |
ATE261941T1 (de) | 1998-12-24 | 2004-04-15 | Lilly Co Eli | Heterocyclische amide als inhibitoren von faktor xa |
DE60022508T2 (de) | 1999-06-14 | 2006-06-08 | Eli Lilly And Co., Indianapolis | Inhibitoren von serin proteasen |
GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
DE10023492A1 (de) * | 2000-05-09 | 2001-11-22 | Schering Ag | Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel |
GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
AU2001280438A1 (en) | 2000-07-27 | 2002-02-13 | Eli Lilly And Company | Substituted heterocyclic amides |
ES2248380T3 (es) | 2000-08-17 | 2006-03-16 | Eli Lilly And Company | Agentes antitromboticos. |
KR100863923B1 (ko) * | 2000-11-22 | 2008-10-17 | 아스텔라스세이야쿠 가부시키가이샤 | 치환된 벤젠 유도체 또는 이의 염 및 이를 포함하는 의약 조성물 |
US7163938B2 (en) | 2000-11-28 | 2007-01-16 | Eli Lilly And Company | Substituted carboxamides |
US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6878714B2 (en) | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US20030134836A1 (en) * | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
US7105682B2 (en) * | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6864255B2 (en) | 2001-04-11 | 2005-03-08 | Amgen Inc. | Substituted triazinyl amide derivatives and methods of use |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
PL370556A1 (en) * | 2001-11-02 | 2005-05-30 | Basf Aktiengesellschaft | Method for producing 2-halogen-pyridine-carboxylic acid amides |
EP1456175A1 (de) | 2001-12-07 | 2004-09-15 | Eli Lilly And Company | Substituierte heterozyklische karboxamide mit antithrombotischer aktivität |
US7307088B2 (en) * | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
HUE025683T2 (hu) | 2002-12-03 | 2016-04-28 | Pharmacyclics Llc | VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok |
EP1581493A1 (de) | 2002-12-30 | 2005-10-05 | Eli Lilly And Company | Faktor-xa-inhibitoren |
DE602004011064T2 (de) * | 2003-05-30 | 2008-12-11 | Eli Lilly And Co., Indianapolis | Antitrombotische aether |
WO2005049604A2 (en) * | 2003-09-30 | 2005-06-02 | Eli Lilly And Company | Antithrombotic aromatic ethers |
ATE457302T1 (de) | 2004-11-24 | 2010-02-15 | Lilly Co Eli | Aromatische etherderivate als thrombin-hemmer |
ATE440833T1 (de) * | 2004-11-29 | 2009-09-15 | Lilly Co Eli | Antithrombotische diamide |
JPWO2006070878A1 (ja) * | 2004-12-28 | 2008-06-12 | アステラス製薬株式会社 | カルボン酸誘導体またはその塩 |
US7264402B2 (en) * | 2005-03-10 | 2007-09-04 | Corning Cable Systems Llc | Multi-fiber optic receptacle and plug assembly |
US8247556B2 (en) | 2005-10-21 | 2012-08-21 | Amgen Inc. | Method for preparing 6-substituted-7-aza-indoles |
FR2926297B1 (fr) | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
HUE043536T2 (hu) * | 2009-10-06 | 2019-08-28 | Millennium Pharm Inc | PDK1 inhibitorként alkalmazható heterociklusos vegyületek |
EP2505198A1 (de) | 2011-04-01 | 2012-10-03 | Société Splicos | Verbindungen zur Verwendung als Therapiemittel mit Beeinträchtigung der p53-Expression und/oder -Aktivität |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1156362A1 (ru) * | 1983-02-17 | 1991-07-30 | Пермский государственный фармацевтический институт | Ариламиды П-(2 @ ,4 @ )- или (3 @ ,4 @ )-диметоксибензилантраниловых кислот как промежуточные вещества дл синтеза биологически активных перхлоратов 1-[(2 @ ,4 @ ) или (3 @ ,4 @ )-диметоксибензил]-2-метил-3-арил-4-(3Н)-хиназолинони |
US5658885A (en) | 1993-04-27 | 1997-08-19 | The Dupont Merck Pharmaceutical Company | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
BR9612423B1 (pt) | 1996-01-02 | 2010-11-30 | composto de n-[(amino-imino-metil ou amino-metil) fenil] propil amidas substituìdas, e, composição farmacêutica. | |
DE19637777C1 (de) | 1996-09-17 | 1997-11-20 | Leica Mikroskopie & Syst | Verfahren und Vorrichtung zur Fehlerkorrektur eines Heterodyn-Interferometers |
AU8270298A (en) * | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
CA2294042A1 (en) * | 1997-06-26 | 1999-01-07 | David Kent Herron | Antithrombotic agents |
EP1007037A4 (de) * | 1997-06-26 | 2004-10-06 | Lilly Co Eli | Antithrombose mittel |
WO1999000126A1 (en) | 1997-06-26 | 1999-01-07 | Eli Lilly And Company | Antithrombotic agents |
US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
PL341044A1 (en) | 1997-12-19 | 2001-03-26 | Schering Ag | Derivatives of orthoantranilic amide as anticoagulants |
ES2226485T3 (es) | 1998-12-23 | 2005-03-16 | Eli Lilly And Company | Amidas aromaticas. |
WO2000039117A1 (en) | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
ATE261941T1 (de) | 1998-12-24 | 2004-04-15 | Lilly Co Eli | Heterocyclische amide als inhibitoren von faktor xa |
US6567857B1 (en) * | 1999-07-29 | 2003-05-20 | Sun Microsystems, Inc. | Method and apparatus for dynamic proxy insertion in network traffic flow |
US6871235B1 (en) * | 1999-12-10 | 2005-03-22 | Nortel Networks Limited | Fast path forwarding of link state advertisements using reverse path forwarding |
US7698463B2 (en) * | 2000-09-12 | 2010-04-13 | Sri International | System and method for disseminating topology and link-state information to routing nodes in a mobile ad hoc network |
US7289505B2 (en) * | 2002-06-04 | 2007-10-30 | Lucent Technologies Inc. | Efficient reverse path forwarding check mechanism |
US7280557B1 (en) * | 2002-06-28 | 2007-10-09 | Cisco Technology, Inc. | Mechanisms for providing stateful NAT support in redundant and asymetric routing environments |
CN1277375C (zh) * | 2003-07-31 | 2006-09-27 | 华为技术有限公司 | 一种光网络中永久连接和交换连接之间的转换方法 |
US20050076099A1 (en) * | 2003-10-03 | 2005-04-07 | Nortel Networks Limited | Method and apparatus for live streaming media replication in a communication network |
-
1999
- 1999-12-15 AT AT99964269T patent/ATE326453T1/de not_active IP Right Cessation
- 1999-12-15 JP JP2000591022A patent/JP2004522689A/ja not_active Withdrawn
- 1999-12-15 AU AU20547/00A patent/AU2054700A/en not_active Abandoned
- 1999-12-15 EP EP99964269A patent/EP1140881B1/de not_active Expired - Lifetime
- 1999-12-15 WO PCT/US1999/029832 patent/WO2000039111A1/en active IP Right Grant
- 1999-12-15 CA CA002358091A patent/CA2358091A1/en not_active Abandoned
- 1999-12-15 ES ES99964269T patent/ES2263294T3/es not_active Expired - Lifetime
- 1999-12-15 DE DE69931393T patent/DE69931393T2/de not_active Expired - Fee Related
- 1999-12-15 US US09/857,747 patent/US6610704B1/en not_active Expired - Fee Related
-
2003
- 2003-02-25 US US10/374,124 patent/US6716855B2/en not_active Expired - Fee Related
- 2003-02-26 US US10/378,108 patent/US6716839B2/en not_active Expired - Fee Related
- 2003-02-28 US US10/377,906 patent/US6710057B2/en not_active Expired - Fee Related
- 2003-03-05 US US10/382,614 patent/US6780878B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2263294T3 (es) | 2006-12-01 |
EP1140881B1 (de) | 2006-05-17 |
US6710057B2 (en) | 2004-03-23 |
US20030199505A1 (en) | 2003-10-23 |
AU2054700A (en) | 2000-07-31 |
CA2358091A1 (en) | 2000-07-06 |
US20030199504A1 (en) | 2003-10-23 |
US20030191153A1 (en) | 2003-10-09 |
EP1140881A1 (de) | 2001-10-10 |
US6716839B2 (en) | 2004-04-06 |
US6716855B2 (en) | 2004-04-06 |
DE69931393D1 (de) | 2006-06-22 |
WO2000039111A1 (en) | 2000-07-06 |
DE69931393T2 (de) | 2007-03-29 |
US20030212069A1 (en) | 2003-11-13 |
US6610704B1 (en) | 2003-08-26 |
US6780878B2 (en) | 2004-08-24 |
JP2004522689A (ja) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE326453T1 (de) | Antithrombotische amide | |
ATE272633T1 (de) | Aromatische amiden | |
ATE374765T1 (de) | Substituierte heterocyclische amide | |
ATE240316T1 (de) | Heteroaromatische amide als inhibitoren von faktor xa | |
ATE297203T1 (de) | Antithrombotische mitteln | |
DE69831868D1 (en) | Antithrombosemittel | |
ATE261941T1 (de) | Heterocyclische amide als inhibitoren von faktor xa | |
FI950309A0 (fi) | Proliiniamidijohdannaisia | |
NO20020214D0 (no) | Substituerte oksozaheterocyklylforbindelser | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
DE602005019316D1 (en) | Aromatische etherderivate als thrombin-hemmer | |
MXPA05011176A (es) | Derivados de carboxamida como agentes antidiabeticos. | |
DE60114640D1 (en) | Antithrombosemittel | |
EA200400806A1 (ru) | Способ получения эхинокандиновых соединений | |
ATE373636T1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
ATE286395T1 (de) | Antithrombotische mittel | |
DE69827614D1 (de) | Chinoxalindionen | |
DE602004011064D1 (en) | Antitrombotische aether | |
ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
IL166313A0 (en) | Indoline derivatives and pharmaceutical compositions containing the same | |
ATE268768T1 (de) | Antithrombosemittel | |
DE60008430D1 (de) | Verbindungen mit antithrombotischer wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |